7th Annual RAS Targeted Drug Development Summit is a conference dedicated to therapeutic opportunity of targeting RAS through novel target site discovery.
Topics
- Evaluating Resistance & Reactivation Within RAS/MAPK Machinery
- Revealing Successes in Allele-Specific Targeting of RAS G12C & Beyond
- Advanced Screening Platforms & Technologies to Guide RAS Drug Discovery
- Tools & Strategies for Drugging High Value Targets Within the RAS/MAPK Pathway
- Novel Biologics & Degradation Mediated Strategies Against RAS Mutant Cancers
- Emerging Strategies to Target a Broad Range of RAS Mutations
Who should Attend
Senior attendees from large pharma, biotech and academia.
